Hydrocortisone Sodium Succinate
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Lifesciences Limited | generic | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 1 | SUPPLYING |
| Cipla USA Inc. | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Hydrocortisone Sodium Succinate Injection — reported in shortage by Cipla Limited. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.
Hydrocortisone Sodium Succinate Injection — reported in shortage by Cipla Limited. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.
